new glp 1 medication FDA says that the GLP-1 shortage is over

The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP 1 weight loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https: cnn.it 49uSrKw The GLP 1 market is projected to reach $164 billion by 2033.# 1 in 5 adults in developed markets has used a GLP 1 drug or knows someone who has. Searches for cost Food companies are targeting users of weight loss drugs with 'GLP 1 Friendly' labels The Associated Press Social media data helps AI flag potential risks of GLP 1 medications Drugs Used for Weight Loss Could Cost Americans Much More Than People in Peer Countries KFF Signs of dumping syndrome to look out for Bariatric surgery can be a huge life saver if you've been struggling with weight and health issues your entire life. And nothing else worked